Log in

Relevant bibliographies by topics / Disease prevention / Books

To see the other types of publications on this topic, follow the link: Disease prevention.

Books on the topic 'Disease prevention'

Author: Grafiati

Published: 4 June 2021

Last updated: 29 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Disease prevention.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Stang, Lucas. Disease prevention. Santa Cruz, Calif: ETR Associates, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Wood, David. Cardiovascular disease prevention. London: Mosby, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Washington (State). Dept. of Health., ed. Chronic disease prevention. Olympia, Wash: The Department, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

S, Garewal Harinder, ed. Antioxidants and disease prevention. Boca Raton: CRC Press, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Allman, Toney. Nutrition and Disease Prevention. New York: Infobase Pub., 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

G, Yanowitz Frank, ed. Coronary heart disease prevention. New York: Dekker, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Allman, Toney. Nutrition and disease prevention. New York: Chelsea House, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

H, Friedlaender Mitchell, and Alta California Eye Research Foundation., eds. Prevention of eye disease. New York, NY: Mary Ann Liebert Inc., 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Warner, Hudson T., ed. Clinical preventive medicine: Health promotion and disease prevention. Boston: Little, Brown, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

J, Murray John, ed. The Prevention of dental disease. 2nd ed. Oxford: Oxford University Press, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Yamamoto, Sho L. Periodontal disease: Symptoms, treatment, and prevention. Hauppauge, N.Y: Nova Science, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Kaplan, Robert M., and Michael H. Criqui, eds. Behavioral Epidemiology and Disease Prevention. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4684-7929-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

United States. Public Health Service. Office of the Surgeon General, ed. Exercise and heart disease prevention. [Washington, D.C.?]: Dept. of Health and Human Services, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

S, Ockene Ira, and Ockene Judith K, eds. Prevention of coronary heart disease. Boston: Little, Brown, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

A, Golper Thomas, and Venkat Raman G, eds. Renal disease: Prevention and treatment. London: Chapman & Hall Medical, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Roehrig, Karla L. Risk factors and disease prevention. Columbus, Ohio (456 Clinic Dr., Columbus 43210): Dept. of Family Medicine, College of Medicine, Ohio State University, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Authority, Newcastle Health, ed. Coronary heart disease prevention policy. Newcastle upon Tyne: Newcastle Health Authority, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Takayuki, Shibamoto, Terao Junji, Osawa Toshihiko, American Chemical Society. Division of Agricultural and Food Chemistry., and American Chemical Society Meeting, eds. Functional foods for disease prevention. Washington, DC: American Chemical Society, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

S Mario Durrant DVM, Jane Fishman Leon, DVM Cody W. Faerber DVM. Canine: Medicine and Disease Prevention. Preston, Idaho: Animal Health Publications, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

NATO Advanced Research Workshop on Behavioral Epidemiology and Disease Prevention (1983 Bellagio Study and Conference Center). Behavioral epidemiology and disease prevention. New York: Plenum, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

J, Murray John, Nunn June H, and Steele J. G, eds. The prevention of oral disease. 4th ed. Oxford: Oxford University Press, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

J, Murray John, ed. The prevention of oral disease. 3rd ed. Oxford: Oxford University Press, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Galle, P. R., W. E. Schmidt, G. Gerken, and B. Wiedenmann, eds. Disease Progression and Disease Prevention in Hepatology and Gastroenterology. Dordrecht: Springer Netherlands, 2006. http://dx.doi.org/10.1007/1-4020-5224-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Muir, Gray J. A., ed. Prevention of disease in the elderly. Edinburgh: Churchill Livingstone, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Martin, Seth S., ed. Precision Medicine in Cardiovascular Disease Prevention. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-75055-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Wilkinson, Michael J., Michael S. Garshick, and Pam R. Taub, eds. Prevention and Treatment of Cardiovascular Disease. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-78177-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Farmer, Nicole M., and Andres Victor Ardisson Korat. Cooking for Health and Disease Prevention. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/b22377.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Kelishadi, Roya, ed. Primordial Prevention of Non Communicable Disease. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-10616-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Disease Prevention. Perfection Learning, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Malvitz. Oral Health Promotion & Disease Prevention: Disease Prevention. W B Saunders Co, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Disease Prevention Cookbook. American Diabetes Association, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Sugano, Michihiro. Soy in Health and Disease Prevention (Nutrition and Disease Preventio). CRC, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Loan, Denis Van. Coronary Heart Disease: Heart Disease Prevention. Independently Published, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Bafadhel, Mona. Prevention of respiratory disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0344.

Full text

Abstract:

The prevention of disease at a population health level rather than an individual health level is aimed at reducing causes of ‘preventable’ death and, under the auspices of public health and epidemiology, is an integral part of primary, secondary, and tertiary care. Classification of death is usually according to the type of primary disease or injury. However, there are a number of recognized risk factors for death, and modifications in behaviour or risk factors can substantially reduce preventable causes of death and the associated healthcare and economic burden of chronic disease management. According to the WHO, hundreds of millions of people from infancy to old age suffer from preventable chronic respiratory diseases, there are over four million deaths annually from preventable respiratory diseases, and common respiratory disorders (e.g. lower respiratory tract infections, chronic obstructive pulmonary disease, lung cancer, and tuberculosis) account for approximately 20% of all deaths worldwide. This chapter discusses the prevention of respiratory disease, covering diseases associated with smoking (one of the biggest risk factors associated with preventable deaths), air pollution, and other lifestyle factors associated with respiratory disease; changes in legislation concerning smoking and work-related respiratory disease; and, finally, the prevention of respiratory diseases through the use of immunization and screening tools.

APA, Harvard, Vancouver, ISO, and other styles

35

Banerjee, Amitava, and Kaleab Asrress. Prevention of cardiovascular disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0343.

Full text

Abstract:

The global scale of the cardiovascular disease epidemic is unquestionable, with cardiovascular disease causing a greater burden of mortality and morbidity than any other disease, regardless of country or population. With demographic change and ageing populations, the prevalence of cardiovascular disease and its risk factors is set to increase. The commonest cardiovascular diseases are atherosclerotic, affecting all arterial territories. The ‘burden of disease’ approach has highlighted the fact that cardiovascular disease and non-communicable diseases are not simply diseases of affluence but affect people of all countries, with enormous costs in terms of public health, healthcare, and overall economies. Coronary artery disease is the leading cause of mortality in all regions of the world apart from sub-Saharan Africa, followed by cerebrovascular disease. It should be noted, however, that there has been a major decline in cardiovascular disease mortality in Western Europe, the US, and Japan over the past 40 years. There are multiple factors underlying these favourable trends but understanding the epidemiology and characterizing individual risk factors for cardiovascular disease has been central in formulating preventive and treatment strategies. The INTERHEART study showed that 90% of cardiovascular risk can be explained by nine easily identifiable risk factors; an awareness of these, and the discovery of novel factors, will continue to serve in the fight to reduce the burden of cardiovascular disease. Geoffrey Rose first championed population-wide approaches versus strategies which target only high-risk individuals. Prevention aims to ‘catch the disease’ upstream, therefore delaying, reducing, or eliminating the risk of coronary artery disease. Surrogate markers for coronary artery disease have emerged in efforts to detect disease at earlier stages, and in order to better understand the pathophysiology. For example, coronary artery calcium scoring is emerging as a marker of future risk of coronary artery disease. Risk stratification scores are increasingly used as tools to individualize a person’s future risk of coronary artery disease in order to better target treatment and prevention strategies.

APA, Harvard, Vancouver, ISO, and other styles

36

Fessenden, Ronald. Disease Prevention Handbook: Strategies for Preventing Disease and Maintaining Good Health. Independently Published, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Chakera, Aron, William G. Herrington, and Christopher A. O’Callaghan. Prevention of kidney disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0345.

Full text

Abstract:

A number of factors are known to predispose to renal disease, such as diabetes mellitus, hypertension, and exposure to certain drugs or substances (e.g. mercury and other heavy metals). In people who are at risk for these reasons, renal function should be regularly monitored as part of routine care. Kidney diseases are identified by elevations in the serum creatinine; the presence in the urine of blood, protein, or elevated levels of certain electrolytes; or evidence of anatomical abnormalities. Due to the large functional reserve of the kidneys, symptoms of impaired renal function usually occur late in the course of disease, highlighting the importance of early detection and, where available, the use of ameliorating therapies.

APA, Harvard, Vancouver, ISO, and other styles

38

Keshav, Satish, and Alexandra Kent. Prevention of gastrointestinal disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0346.

Full text

Abstract:

Disease prevention is usually directed where there is considerable morbidity or mortality, and etiological factors that can be controlled, treated, or reduced. The greatest morbidity and mortality from gastrointestinal disease is related to infectious diarrhoea and gastrointestinal cancer, both of which can be prevented. Smoking has been closely associated with oesophageal, gastric, and liver cancer and also has a significant effect in inflammatory bowel disease. In addition, alcohol consumption and viral hepatitis are preventable causes of liver disease, liver failure, and hepatic cancer. This chapter addresses the prevention of gastrointestinal disease, focusing on alcohol, smoking, peptic ulcer disease, colorectal cancer, oesophageal adenocarcinoma, hepatitis B, hepatitis C, non-alcoholic fatty liver disease, and gastrointestinal infection.

APA, Harvard, Vancouver, ISO, and other styles

39

Morrison, Karen. Prevention of neurological disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0347.

Full text

Abstract:

Neurological disease is very common. It is estimated that one-third of consultations with general practitioners involve neurological complaints, and neurological disorders are present in one-third of patients admitted to hospital. In considering how to reduce the incidence of neurological disease, one must take into account the feasibility of prevention, and the overall morbidity caused by the disease. In stroke, which is very common, interventions which reduce incidence by a small percentage have the potential to have a large impact on a population basis. A disorder such as migraine, while not life-limiting, accounts for significant morbidity and time off work (one study suggests that there are the equivalent of 112 million bedridden days per year due to migraine alone), so, again, interventions that reduce the frequency of episodes even by a small percentage can have great overall impact. This chapter discusses the major categories of neurological disease based on pathogenesis, and current and future approaches to prevention.

APA, Harvard, Vancouver, ISO, and other styles

40

Morrison, Karen. Prevention of cerebrovascular disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0348.

Full text

Abstract:

Stroke is the main cause of neurological morbidity in adults and the third most common cause of death worldwide after ischaemic heart disease and cancer (all forms combined). It is more common in older people, with three-quarters of strokes occurring in people over 65 years of age, and estimates are that overall stroke morbidity will double by the early 2020s. The worldwide figure of increasing incidence of stroke detection masks the fact that mortality from stroke has actually been falling in developed countries since the latter half of the twentieth century while the mortality has continued to rise in China, Asia, and eastern Europe. This chapter discusses prevention of cerebrovascular disease, and includes strategies to reduce the risk of thromboembolic stroke and cerebral haemorrhage.

APA, Harvard, Vancouver, ISO, and other styles

41

Isaranuwatchai, Wanrudee, Rachel A. Archer, Yot Teerawattananon, and Anthony Culyer, eds. Non-communicable Disease Prevention. Open Book Publishers, 2019. http://dx.doi.org/10.11647/obp.0195.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Holland, Walter W., and Susie Stewart. Screening in Disease Prevention. CRC Press, 2018. http://dx.doi.org/10.1201/9781315377537.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Foundation, Life Extension. Disease Prevention and Treatment. 4th ed. Life Extension Media, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

Stein, Mary. Cardiovascular Disease: Evaluation & Prevention. Western Schools, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Segala, Melanie. Disease Prevention and Treatment. 3rd ed. Life Extension Media, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Harber. Prevention Of Pulm Disease. Hanley & Belfus, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

S Sue Khuon Bs Ma. Disease Prevention and Longevity. Page Publishing, Inc., 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Evans, C. De Lacy. The Prevention Of Disease. Kessinger Publishing, LLC, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

(Editor), Michael Grundman, and Leon J. Thal (Editor), eds. Prevention of Alzheimer's Disease. Martin Dunitz, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

50

S. Sue Khuon Bs Ma. Disease Prevention and Longevity. Page Publishing Inc., 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!